Fig. 1
From: A versatile platform for chemical engineering of exosomes empowered by ADP-ribosyl cyclases
Schematic of the development of site-specifically functionalized ARC Exos by utilizing surface-anchored CD38 enzyme and its covalent inhibitor 2′-Cl-araNAD+.
